Synergy of Drugs and Devices for Treating PAD: A Concerted Approach to Improve Patient Outcomes

Learning Objectives

List benefit of DCB and DES over BMS and PTA
Explain advantages and disadvantages of DCB over DES
Describe the concept of leave nothing behind
Outline global data on drug delivery for long lesions

Moderator and Faculty

Moderator: Teresa Carman, MD, University Hospitals of Cleveland
Elissa Altin, MD, Yale University and VA Connecticut
Subhash Banerjee, MD, University of Texas Southwestern Medical Center
Herbert Aronow, MD, MPH, Lifespan
Manesh Patel, MD, Duke University School of Medicine
Mehdi H. Shishehbor, DO, MPH, PhD, University Hospitals of Cleveland